v3.26.1
Document And Entity Information
May 11, 2026
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 11, 2026
Entity Registrant Name Metagenomi Therapeutics, Inc.
Entity Central Index Key 0001785279
Entity Emerging Growth Company true
Entity File Number 001-41949
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 81-3909017
Entity Address, Address Line One 5959 Horton Street
Entity Address, Address Line Two 7th Floor
Entity Address, City or Town Emeryville
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code (510)
Local Phone Number 871-4880
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol MGX
Security Exchange Name NASDAQ